Awards
Prix Galien Award 2006 (Otsuka France)
We are immensely proud that our innovation and creativity in Europe has been recognised with a number of awards and accreditations, as follows:
  • 2003 – Neuro-Depesche Innovation Award (Germany)
  • 2005 – Pharma Barometer, Most Innovative Neurological Product (Germany)
  • 2005 – Diario Médico Best Idea of the Year – Research and Pharmacology (Spain)
  • 2006 – Pharma Barometer: Most Innovative Product for psychiatry/neurology (Germany)
  • 2006 – Prix Galien: Most Innovative Product on the Retail Market in France (France)
  • 2006 – Prix Abstract Psychiatrie: Prix Impact Medecine de L’Innovation (France)
  • 2007 – Pharma Barometer: Most Innovative Product for psychiatry/neurology (Germany)
  • 2011 – Customer Focus Award (highly commended) at the Pharmaceutical Marketing Excellence Awards (Otsuka Europe)
  • 2012 – Communiqué Award for the Best Communication of Scientific Data via the European Hyponatraemia Network (Otsuka Europe)
  • 2013 – RX Club Print Award of Excellence for hyponatraemia symptom awareness campaign (Otsuka Europe)
  • 2013 – RX Club Interactive Award of Excellence for hyponatraemia symptom awareness campaign (Otsuka Europe)
  • 2014 – Astrid Award, a design prize for Outstanding Achievement of Design Communications for hyponatraemia awareness raising campaign (Germany)
  • 2014 – Redacción Médica (Editorial) Top 10 E+D award for Deltyba®, chosen by readers as the second most relevant pharmacological innovation in 2013 (Spain)
  • 2014 – National Training Awards (commendation) (UK)
  • 2014 – Investor in People (Gold) accreditation (UK)